Olr235 inhibitors represent a specialized class of chemical compounds designed to selectively modulate the activity of the Olr235 receptor, a G protein-coupled receptor (GPCR) within the olfactory receptor (OR) family. These inhibitors function by binding to specific sites on the Olr235 receptor, thereby preventing or altering the binding of endogenous ligands, which are typically odorant molecules. The interaction between an Olr235 inhibitor and the receptor leads to a cascade of intracellular events that ultimately diminish the receptor's ability to transduce signals related to olfactory perception. This inhibition is highly specific, often requiring intricate molecular design to achieve the desired selectivity, as olfactory receptors share considerable structural homology.
The molecular architecture of Olr235 inhibitors often involves complex aromatic systems that enable them to fit precisely within the binding pocket of the Olr235 receptor. This precision is critical as the Olr235 receptor, like other olfactory receptors, operates through a finely tuned recognition system, where even minor alterations in the chemical structure of an inhibitor can significantly impact its binding affinity and efficacy. Furthermore, the design of these inhibitors must account for the dynamic nature of GPCRs, which can undergo conformational changes upon ligand binding. As such, Olr235 inhibitors are typically studied extensively through computational modeling and structure-activity relationship (SAR) studies to ensure optimal interaction with the receptor. Understanding the chemical properties of these inhibitors not only provides insights into the structural biology of olfactory receptors but also contributes to broader research areas, such as receptor-ligand interactions and the fundamental mechanisms governing GPCR signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aripiprazole | 129722-12-9 | sc-207300 sc-207300A sc-207300B | 100 mg 1 g 5 g | $179.00 $212.00 $1037.00 | 3 | |
Atypical antipsychotic, can modulate dopamine and serotonin pathways, potentially influencing Olr235. | ||||||
Carbamazepine | 298-46-4 | sc-202518 sc-202518A | 1 g 5 g | $33.00 $71.00 | 5 | |
Anticonvulsant, might affect sodium channels and neurotransmitter signaling, impacting Olr235. | ||||||
Erlotinib Hydrochloride | 183319-69-9 | sc-202154 sc-202154A | 10 mg 25 mg | $75.00 $121.00 | 33 | |
EGFR inhibitor, may influence cell growth and signaling pathways, affecting Olr235. | ||||||
Fluconazole | 86386-73-4 | sc-205698 sc-205698A | 500 mg 1 g | $54.00 $84.00 | 14 | |
Antifungal, can disrupt fungal cell membrane synthesis, potentially impacting Olr235 indirectly. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
Lipid-regulating agent, might modulate lipid metabolism, impacting Olr235. | ||||||
13-cis-Retinoic acid | 4759-48-2 | sc-205568 sc-205568A | 100 mg 250 mg | $75.00 $120.00 | 8 | |
Retinoid, may influence cell differentiation and proliferation, affecting Olr235. | ||||||
Lamotrigine | 84057-84-1 | sc-201079 sc-201079A | 10 mg 50 mg | $120.00 $486.00 | 1 | |
Anticonvulsant, can modulate sodium channels and neurotransmitter release, impacting Olr235. | ||||||
Raloxifene | 84449-90-1 | sc-476458 | 1 g | $802.00 | 3 | |
Selective estrogen receptor modulator, could affect estrogen signaling, impacting Olr235. | ||||||
Topiramate | 97240-79-4 | sc-204350 sc-204350A | 10 mg 50 mg | $107.00 $369.00 | ||
Anticonvulsant, may modulate GABAergic signaling and ion channels, affecting Olr235. | ||||||